Dtsch Med Wochenschr 2006; 131(39): 2158
DOI: 10.1055/s-2006-951345
Pro & Contra | Commentary
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Therapie des Vorhofflimmerns - das Ziel ist Rhythmuskontrolle

Treatment of atrial fibrillation - the goal is rhythm controlS. Ernst1 , K.-H Kuck1
  • 1II. Med. Abteilung, St. Georg, Hanseatisches Herzzentrum, Hamburg
Further Information

Publication History

eingereicht: 8.8.2006

akzeptiert: 10.8.2006

Publication Date:
22 September 2006 (online)

Literatur

  • 1 Corley S D, Epstein A E, DiMarco J P. et al; AFFIRM Investigators . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.  Circulation. 2004;  109 1509-1513
  • 2 Singh B N, Singh S N, Reda D J. et al . Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation.  N Engl J Med. 2005;  352 1861-1872
  • 3 Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients.  Circulation. 2005;  112 1214-1222
  • 4 Wazni O M, Marrouche N F, Martin D O. et al . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.  J Am Med Assoc. 2005;  293 2634-2640

Prof. Dr. med. Karl-Heinz Kuck

II. Medizinische Abteilung, Klinik St. Georg

Lohmuehlenstr. 5

20099 Hamburg

Phone: 49/40/1818852305

Fax: 49/40/1818854444

Email: sernst1708@aol.com

    >